PTGES2 blocking peptide product blog
Tags: Blocking Peptide; PTGES2; PTGES2 blocking peptide;
The PTGES2 ptges2 (Catalog #MBS9230403) is a Blocking Peptide and is intended for research purposes only. The product is available for immediate purchase.The PTGES2 ptges2 product has the following accession number(s) (GI #73921741) (NCBI Accession #Q9H7Z7.1) (Uniprot Accession #Q9H7Z7). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Isomerase that catalyzes the conversion of PGH2 into the more stable prostaglandin E2 (PGE2).
Cellular Location: Golgi apparatus membrane; Single-pass membrane protein. Tissue Location: Widely expressed. Expressed in the heart, including apex, inter-ventricular septum, both atria and ventricles, but not in the aorta. Also expressed in fetal heart Detected in various regions of the brain: cerebellum; occipital, frontal and parietal lobes. Also expressed in the lymph nodes, skeletal muscle, kidney and trachea, but not in the thymus or lung. Overexpressed in colorectal cancer. Breast Neoplasms, Carcinoma, Cardiovascular Diseases, Inflammation, Insulin Resistance, Neoplasms, Experimental, Prenatal Exposure Delayed Effects are some of the diseases may be linked to PTGES2 Blocking Peptide (Center). Blood, Embryonic Tissue, Lung, Mammary Gland, Ovary, Prostate, Uterus, Vascular tissues are correlated with this protein. The following patways have been known to be associated with this gene.